Bankole Simbo Asebiomo, MD

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Asebiomo’s office at (229) 391-4100 to ask if they take your plan before you enroll.

California Medical Board record

Licence C163303 · Current

Licensed to practise in California · since 2019 · expires 2027-07-31 · University of Ibadan College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Medicaid work

$1,001 in 2018

Medicaid paid $1,001 for 31 billed services this clinician did in 2018, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2018

Return visit (30+ min)	31	$1,001

Sort by

Medicaid work by year

2018	31	1	14	$1,001

Drugs they prescribed that Part D paid

$1,318,249

Pharmacies billed $1,318,249 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 397) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.

70 generic and 327 brand-name prescriptions · $1,318,249 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Biktarvy	124	$525,644	$4,239
Genvoya	69	$325,055	$4,711
Tivicay	21	$97,187	$4,628
Prezcobix	36	$97,153	$2,699
Symtuza	14	$71,195	$5,085

See all 9 drugs

Sort by

Every Part D drug this clinician prescribed

Biktarvy	124	$525,644	$4,239
Genvoya	69	$325,055	$4,711
Tivicay	21	$97,187	$4,628
Prezcobix	36	$97,153	$2,699
Symtuza	14	$71,195	$5,085
Dovato	20	$63,528	$3,176
Triumeq	16	$61,633	$3,852
Isentress Hd	11	$25,467	$2,315
Abacavir	13	$2,010	$155

Year by year

Sort by

Part D prescribing by year

2024	397	49	0% (0)	82%	$1,318,249
2023	464	51	0% (0)	82%	$1,410,383
2022	434	42	0% (0)	74%	$1,094,483
2021	500	64	0% (0)	76%	$1,196,894
2020	580	57	0% (0)	72%	$1,211,019
2019	773	83	None	64%	$1,384,768
2018	778	114	0% (0)	58%	$1,331,463
2017	528	88	None	51%	$533,224
2016	220	53	0% (0)	42%	$184,872
2015	185	35	None	42%	$71,154
2014	294	16	0% (0)	42%	$101,055
2013	382	34	None	None	$139,920

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 7 drugs

Sort by

Part D drugs prescribed in 2023

Biktarvy	154	$634,072	$4,117
Genvoya	83	$351,975	$4,241
Dovato	27	$82,973	$3,073
Prezcobix	28	$72,930	$2,605
Triumeq	15	$56,769	$3,785
Descovy	12	$27,723	$2,310
Edurant	12	$17,337	$1,445

2022: 12 drugs

Sort by

Part D drugs prescribed in 2022

Biktarvy	113	$437,731	$3,874
Genvoya	61	$234,815	$3,849
Triumeq	25	$88,273	$3,531
Dovato	22	$63,339	$2,879
Tivicay	18	$60,217	$3,345
Symtuza	12	$55,389	$4,616
Descovy	21	$45,940	$2,188
Prezista	13	$26,251	$2,019
Edurant	11	$15,135	$1,376
Efavirenz	16	$2,544	$159
Fluconazole	14	$772	$55
Sulfamethoxazole-Trimethoprim	20	$207	$10

2021: 10 drugs

Sort by

Part D drugs prescribed in 2021

Biktarvy	110	$402,124	$3,656
Genvoya	65	$235,252	$3,619
Triumeq	44	$147,177	$3,345
Dovato	45	$121,876	$2,708
Tivicay	17	$48,599	$2,859
Descovy	22	$44,686	$2,031
Stribild	11	$41,713	$3,792
Prezista	15	$28,808	$1,921
Fluconazole	12	$579	$48
Sulfamethoxazole-Trimethoprim	18	$84	$5

2020: 16 drugs

Sort by

Part D drugs prescribed in 2020

Biktarvy	93	$330,963	$3,559
Triumeq	61	$198,346	$3,252
Genvoya	53	$190,641	$3,597
Tivicay	52	$117,323	$2,256
Descovy	42	$80,791	$1,924
Prezcobix	26	$53,678	$2,065
Prezista	23	$41,188	$1,791
Stribild	11	$39,237	$3,567
Intelence	12	$17,148	$1,429
Abacavir	22	$6,656	$303
Efavirenz	12	$5,321	$443
Ritonavir	24	$2,246	$94
Tenofovir Disoproxil	14	$1,791	$128
Lamivudine	11	$964	$88
Fluconazole	13	$619	$48
Sulfamethoxazole-Trimethoprim	28	$267	$10

2019: 19 drugs

Sort by

Part D drugs prescribed in 2019

Triumeq	101	$309,804	$3,067
Genvoya	90	$294,710	$3,275
Biktarvy	78	$255,865	$3,280
Tivicay	48	$110,191	$2,296
Descovy	41	$74,744	$1,823
Prezcobix	27	$53,571	$1,984
Complera	15	$44,093	$2,940
Odefsey	14	$41,260	$2,947
Prezista	21	$36,863	$1,755
Truvada	13	$23,279	$1,791
Abacavir	23	$6,539	$284
Tenofovir Disoproxil	25	$2,529	$101
Fluconazole	22	$1,825	$83
Ritonavir	19	$1,615	$85
Valacyclovir	16	$1,350	$84
Rifampin	14	$976	$70
Cefadroxil	16	$841	$53
Azithromycin	18	$660	$37
Sulfamethoxazole-Trimethoprim	42	$371	$9

2018: 23 drugs

Sort by

Part D drugs prescribed in 2018

Triumeq	107	$336,821	$3,148
Genvoya	52	$166,452	$3,201
Tivicay	44	$84,441	$1,919
Biktarvy	19	$76,770	$4,041
Atripla	20	$62,549	$3,127
Complera	16	$54,510	$3,407
Prezcobix	25	$45,824	$1,833
Truvada	24	$41,434	$1,726
Stribild	12	$38,104	$3,175
Descovy	17	$29,094	$1,711
Prezista	18	$27,708	$1,539
Isentress	15	$22,791	$1,519
Intelence	13	$15,950	$1,227
Viread	13	$11,753	$904
Tenofovir Disoproxil	11	$9,172	$834
Abacavir	21	$8,677	$413
Meropenem	19	$8,213	$432
Doxycycline Hyclate	20	$2,598	$130
Rifampin	17	$1,295	$76
Fluconazole	26	$1,173	$45
Lamivudine	11	$1,155	$105
Cefadroxil	20	$755	$38
Sulfamethoxazole-Trimethoprim	28	$187	$7

2017: 19 drugs

Sort by

Part D drugs prescribed in 2017

Triumeq	45	$119,950	$2,666
Atripla	24	$63,795	$2,658
Complera	17	$56,365	$3,316
Tivicay	26	$51,307	$1,973
Genvoya	14	$39,674	$2,834
Truvada	21	$36,823	$1,753
Viread	16	$25,852	$1,616
Isentress	13	$18,496	$1,423
Prezista	12	$15,870	$1,322
Norvir	12	$10,356	$863
Monurol	11	$3,542	$322
Vancomycin	15	$2,608	$174
Rifampin	16	$1,248	$78
Fluconazole	22	$794	$36
Ceftriaxone	23	$707	$31
Azithromycin	14	$558	$40
Sulfamethoxazole-Trimethoprim	20	$336	$17
Metronidazole	12	$304	$25
Minocycline	12	$168	$14

2016: 6 drugs

Sort by

Part D drugs prescribed in 2016

Atripla	12	$28,653	$2,388
Meropenem	12	$4,236	$353
Vancomycin	14	$3,037	$217
Fluconazole	14	$675	$48
Sulfamethoxazole-Trimethoprim	11	$135	$12
Amoxicillin	11	$84	$8

2015: 4 drugs

Sort by

Part D drugs prescribed in 2015

Prezista	14	$17,784	$1,270
Norvir	20	$5,717	$286
Omeprazole	12	$58	$5
Hydrochlorothiazide	11	$51	$5

2014: 12 drugs

Sort by

Part D drugs prescribed in 2014

Tivicay	21	$35,598	$1,695
Prezista	23	$27,226	$1,184
Truvada	14	$15,548	$1,111
Norvir	24	$6,300	$262
Lansoprazole	11	$754	$69
Digox	12	$340	$28
Levothyroxine	16	$167	$10
Hydrochlorothiazide	14	$117	$8
Warfarin	13	$98	$8
Omeprazole	13	$75	$6
Lisinopril	12	$52	$4
Furosemide	13	$38	$3

2013: 14 drugs

Sort by

Part D drugs prescribed in 2013

Prezista	39	$43,782	$1,123
Truvada	27	$28,942	$1,072
Norvir	40	$14,010	$350
Reyataz	11	$12,360	$1,124
Isentress	11	$11,968	$1,088
Benicar	13	$1,896	$146
Stavudine	11	$967	$88
Omeprazole	25	$363	$15
Hydrochlorothiazide	13	$164	$13
Warfarin	16	$164	$10
Digox	11	$144	$13
Lisinopril	17	$133	$8
Levothyroxine	13	$99	$8
Atenolol	12	$73	$6

Money from drug and device companies

$16 in 2024

Sort by

Industry payments by year

2024	1	1	None	$16
2023	2	2	None	$35
2022	4	5	None	$163
2021	2	2	None	$49
2020	3	5	None	$164
2019	4	4	None	$58

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Gilead Sciences	None	$16	1 payment Meals · 2024-04-26 · $16

See the published payment

Sort by

Every published payment

Gilead Sciences	Meals · 2024-04-26	None	$16

See earlier years (2023, 2022, 2021, 2020, 2019)

2023: $35

Sort by

Payments by company in 2023

Gilead Sciences	None	$18	1 payment Meals · 2023-02-02 · $18
ViiV Healthcare	Rukobia	$17	1 payment Meals for Rukobia · 2023-04-11 · $17

2022: $163

Sort by

Payments by company in 2022

Janssen Products LP	Symtuza	$100	1 payment Education for Symtuza · 2022-04-04 · $100
ViiV Healthcare	Dovato	$34	2 payments Meals for Rukobia · 2022-12-13 · $16 Meals for Dovato · 2022-03-17 · $18
Gilead Sciences	None	$15	1 payment Meals · 2022-10-19 · $15
Janssen Biotech	Symtuza	$14	1 payment Meals for Symtuza · 2022-07-20 · $14

2021: $49

Sort by

Payments by company in 2021

ViiV Healthcare	Dovato	$33	1 payment Meals for Dovato · 2021-08-20 · $33
Janssen Biotech	Symtuza	$17	1 payment Meals for Symtuza · 2021-02-11 · $17

2020: $164

Sort by

Payments by company in 2020

Janssen Products LP	Symtuza	$100	1 payment Education for Symtuza · 2020-10-29 · $100
ViiV Healthcare	Dovato	$39	2 payments Meals for Dovato · 2020-12-16 · $16 Meals for Dovato · 2020-08-18 · $23
Janssen Biotech	Symtuza	$25	2 payments Meals for Symtuza · 2020-09-24 · $10 Meals for Symtuza · 2020-05-20 · $15

2019: $58

Sort by

Payments by company in 2019

Gilead Sciences	None	$19	1 payment Meals · 2019-08-01 · $19
ViiV Healthcare	Triumeq	$15	1 payment Meals for Triumeq · 2019-01-24 · $15
Merck Sharp & Dohme	Isentress	$13	1 payment Meals for Isentress · 2019-01-24 · $13
Melinta Therapeutics	Vabomere	$11	1 payment Meals for Vabomere · 2019-01-24 · $11

Professional record

NPI: 1841301884
Licence: CA C163303, GA 045706, VA 0101242047California C163303: Current · expires 2027-07-31

More record details

Sole proprietor: No
Medicaid ID: GA 000849329D, VA 1841301884
Taxonomy: Internal medicine (207R00000X); Federal specialty code 207RI0200X (207RI0200X); Hospitalist (208M00000X)
Mailing address: 3041 Sky Watch Way, Roseville, CA, 95747
NPI first listed: 2006-08-31
NPI last updated: 2023-04-28
NPI record certified: 2023-04-28

This is when the NPI record was last certified, not a medical board exam.